Determination of regional intestinal permeability of diclofenac and metoprolol using a newly-developed and validated high performance liquid chromatographic method

Tropical Journal of Pharmaceutical Research

Volumn 14, Issue 1, 2015, Pages 163-170

  Kaynak, Mustafa Sinan ^a,b   Buyuktuncel, Ebru ^b   Caglar, Hatice ^b   Sahin, Selma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Biopharmaceutics classification system; Diclofenac; Intestinal absorption; Metoprolol tartrate; Segmental permeability; Validation

Indexed keywords

DICLOFENAC; METOPROLOL TARTRATE; PHENOLSULFONPHTHALEIN; PROPYL PARABEN;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; ENVIRONMENTAL TEMPERATURE; FEMALE; FLOW RATE; ILEUM; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LINEARITY; MEASUREMENT ACCURACY; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY; SYSTEM SUITABILITY; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 84922013974     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v14i1.23     Document Type: Article

References (20)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. A Theoretical basis for a Biopharmaceutic Drug Classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm Res 1995; 12: 413-420.
2. Zakeri-Milani P, Valizadeh H, Azarmi Y, Jalali MB, Tajerzadeh H. Simultaneous determination of metoprolol, propranolol and phenol red in samples from rat in situ intestinal perfusion studies DARU 2006; 14: 102-108.
3. Nagare N, Damre A, Singh KS, Mallurwar SR, Iyer S, Naik A, Chintamaneni M. Determination of site of absorption of propranolol in rat gut using in situ single-pass intestinal perfusion. Indian J Pharm Sci 2010; 72: 625-U315.
4. Lennernas H, Abrahamsson B. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J Pharm Pharmacol 2005; 57: 273-285.
5. Chuasuwan B, Binjesoh V, Polli JE, Zhang H, Amidon GL, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB et al. Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium. J Pharm Sci 2009; 98: 1206-1219.
6. Terhaag B, Hoffmann A, Barkworth M, Vens-Cappell B. Bioavailability of a new effervescent tablet of diclofenac. Int J Clin Pharmacol Ther 2000; 38: 546-551.
7. Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 1979; 16: 405-410.
8. Kaphalia L, Kaphalia BS, Kumar S, Kanz MF, Treinen-Moslen M. Efficient high performance liquid chromatograph/ultraviolet method for determination of diclofenac and 4′-hydroxydiclofenac in rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830: 231-237.
9. Klimes J, Sochor J, Dolezal P, Korner J. HPLC evaluation of diclofenac in transdermal therapeutic preparations. Int J Pharm 2001; 217: 153-160.
10. Sane RT, Samant RS, Nayak VG. High-Performance Liquid-Chromatographic determination of diclofenac sodium from pharmaceutical preparation. Drug Dev Ind Pharm 1987; 13: 1307-1314.
11. Beaulieu N, Lovering EG, Lefrancois J, Ong H. Determination of diclofenac sodium and relatedcompounds in raw-materials and formulations. J Assoc Anal Chem 1990; 73: 698-701.
12. ICH. Expert Working Group. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology Q2R1 [cited 2014 Feb 20]. Available from: http://www.ich. org/products/guidelines/quality/ article/quality-guidelines. html.
13. Kim JS, Mitchell S, Kijek P, Tsume Y, Hilfinger J, Amidon GL. The suitability of an in situ perfusion model for permeability determinations: Utility for BCS class I biowaiver requests. Mol Pharm 2006; 3: 686-694.
14. Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 1996; 13: 1336-1342.
15. Komiya I, Park JY, Kamani A, Ho NFH, Higuchi WI. Quantitative mechanistic studies in simultaneous fluid-flow and intestinal-absorption using steroids as model solutes. Int J Pharm 1980; 4: 249-262.
16. Dahan A, Amidon GL. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Mol Pharm 2009; 6: 19-28.
17. Patel JR, Barve KH. Intestinal permeability of lamivudine using single pass intestinal perfusion. Indian J Pharm Sci 2012; 74: 478-U433.
18. Lennernas H. Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev 2007; 59: 1103-1120.
19. Incecayir T, Tsume Y, Amidon GL. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Mol Pharm 2013; 10: 958-966.
20. Idkaidek NM, Jilani JA, Mansi IA. Evaluation of hydroxyethyldiclofenac intestinal absorption in rats Saudi Pharm J 2005; 13: 158-163.